Ethno-racial differences in depressive symptom endorsement: Evaluation of brief forms of the Geriatric Depression Scale in older adults.

Alzheimer's Dementia Depression Measurement Race/ethnicity

Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
13 Aug 2024
Historique:
received: 08 04 2024
revised: 11 08 2024
accepted: 12 08 2024
medline: 16 8 2024
pubmed: 16 8 2024
entrez: 15 8 2024
Statut: aheadofprint

Résumé

Depression among older adults is a pressing public health concern, necessitating accurate assessment tools. The Geriatric Depression Scale (GDS) offers a brief and efficient means of screening depressive symptoms, yet its performance across ethno-racial groups remains understudied. This study aimed to compare the ability of various brief forms of the GDS to detect depressive symptoms and to assess potential ethno-racial differences in symptom endorsement among White, Black/African-American, and American Indian/Alaska Native older adults. Data were obtained from the Wisconsin Alzheimer's Disease Research Center (ADRC) clinical cohort, comprising 555 cognitively healthy individuals at risk for dementia. We used participants' baseline data for this cross-sectional analysis. Depressive symptoms were assessed using multiple brief forms of the GDS, derived from a systematic review and meta-analysis. We examined internal consistency and correlations with global Clinical Dementia Rating (CDR) scores. We conducted Kruskal-Wallis tests and post hoc pairwise comparisons to assess ethno-racial group differences in symptom endorsement. Descriptive statistics revealed a predominance of female and White participants, with notable representation from Black and American Indian/Alaska Native groups. All GDS versions demonstrated moderate to high internal consistency. Significant positive correlations were observed between GDS scores and global CDR scores. Ethno-racial group differences in depressive symptom endorsement were evident, with Black participants consistently reporting higher levels of symptoms across most GDS versions. However, American Indian/Alaska Native participants endorsed significantly fewer symptoms than Black participants in one GDS version. The study highlights the importance of considering ethno-racial differences in depressive symptomatology when assessing older adults. While the GDS demonstrates overall reliability, variations in symptom endorsement across different ethno-racial groups underscore the need for culturally sensitive assessment tools and interventions. Future research should further explore these group differences and develop tailored approaches to depression screening and treatment in diverse older adult populations.

Sections du résumé

BACKGROUND BACKGROUND
Depression among older adults is a pressing public health concern, necessitating accurate assessment tools. The Geriatric Depression Scale (GDS) offers a brief and efficient means of screening depressive symptoms, yet its performance across ethno-racial groups remains understudied. This study aimed to compare the ability of various brief forms of the GDS to detect depressive symptoms and to assess potential ethno-racial differences in symptom endorsement among White, Black/African-American, and American Indian/Alaska Native older adults.
METHODS METHODS
Data were obtained from the Wisconsin Alzheimer's Disease Research Center (ADRC) clinical cohort, comprising 555 cognitively healthy individuals at risk for dementia. We used participants' baseline data for this cross-sectional analysis. Depressive symptoms were assessed using multiple brief forms of the GDS, derived from a systematic review and meta-analysis. We examined internal consistency and correlations with global Clinical Dementia Rating (CDR) scores. We conducted Kruskal-Wallis tests and post hoc pairwise comparisons to assess ethno-racial group differences in symptom endorsement.
RESULTS RESULTS
Descriptive statistics revealed a predominance of female and White participants, with notable representation from Black and American Indian/Alaska Native groups. All GDS versions demonstrated moderate to high internal consistency. Significant positive correlations were observed between GDS scores and global CDR scores. Ethno-racial group differences in depressive symptom endorsement were evident, with Black participants consistently reporting higher levels of symptoms across most GDS versions. However, American Indian/Alaska Native participants endorsed significantly fewer symptoms than Black participants in one GDS version.
CONCLUSION CONCLUSIONS
The study highlights the importance of considering ethno-racial differences in depressive symptomatology when assessing older adults. While the GDS demonstrates overall reliability, variations in symptom endorsement across different ethno-racial groups underscore the need for culturally sensitive assessment tools and interventions. Future research should further explore these group differences and develop tailored approaches to depression screening and treatment in diverse older adult populations.

Identifiants

pubmed: 39147158
pii: S0165-0327(24)01276-X
doi: 10.1016/j.jad.2024.08.063
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflict of interest.

Auteurs

Emre Umucu (E)

Public Health Sciences, The University of Texas at El Paso, El Paso, TX, United States. Electronic address: eumucu@utep.edu.

Diane Carol Gooding (DC)

Department of Psychology, University of Wisconsin-Madison, Madison, WI, United States; Division of Geriatrics, Department of Medicine, The School of Medicine and Public Health (SMPH), University of Wisconsin-Madison, Madison, WI, United States.

Teresa Granger (T)

The University of Alabama, Tuscaloosa, AL, United States.

Mary Wyman (M)

W. S. Middleton Memorial Veterans Hospital, Madison, WI, United States; School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States.

Nick Lambrou (N)

W. S. Middleton Memorial Veterans Hospital, Madison, WI, United States.

Marlene Summers (M)

Alzheimer's Disease Research Center, University of Wisconsin-Madison, Madison, WI, United States.

Lois Strong (L)

Alzheimer's Disease Research Center, University of Wisconsin-Madison, Madison, WI, United States.

Wes Martin (W)

Alzheimer's Disease Research Center, University of Wisconsin-Madison, Madison, WI, United States.

Fabu Carter (F)

W. S. Middleton Memorial Veterans Hospital, Madison, WI, United States.

Shenikqua Bouges (S)

Alzheimer's Disease Research Center, University of Wisconsin-Madison, Madison, WI, United States.

Adrienne Johnson (A)

UW Center for Tobacco Research and Intervention, United States.

Carey E Gleason (CE)

Alzheimer's Disease Research Center, University of Wisconsin-Madison, Madison, WI, United States; Division of Geriatrics, Department of Medicine, The School of Medicine and Public Health (SMPH), University of Wisconsin-Madison, Madison, WI, United States; Geriatric Research, Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison, WI, United States.

Classifications MeSH